Table 2:

Comparison of overall survival by relative ADC and glioma IDH-mutation status

Variable^{^a}	Case No.	Survival Time^{^b}	Coefficient (β)	P Value
IDH mutant, high rADC_mean	63	62.0
vs IDH mutant, low rADC_mean			.141	.003
vs IDH wild-type, high rADC_mean			.06	<.001
vs IDH wild-type, low rADC_mean			.24	<.001
IDH mutant, low rADC_mean	9	24.2 (0.0–55.0)
vs IDH wild-type, high rADC_mean			.45	.614
IDH wild-type, high rADC_mean	30	17.7 (11.6–23.7)
vs IDH wild-type, low rADC_mean			.25	.041
IDH wild-type, low rADC_mean	29	10.4 (4.4–16.4)
vs IDH mutant, low rADC_mean			.51	.179

↵a High rADC_mean: rADC_mean values ≥ 1.08; low rADC_mean: rADC_mean values < 1.08.
↵b Survival time is expressed as median (95% CI) (months).